Multicenter, Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-group, Ambulatory Safety and Efficacy Study of ARK-E021 Topical Foam of 5% and 10% in Subjects With Mild to Moderate Acne Vulgaris.
This is a multicenter, randomized, double-blind, placebo-controlled, 3-arm, parallel-group, ambulatory safety and efficacy study of ARK-E021 topical foam of 5% and 10% in subjects with mild to moderate acne vulgaris.
100 项与 M. Arkin (1999) Ltd. 相关的临床结果
0 项与 M. Arkin (1999) Ltd. 相关的专利（医药）
100 项与 M. Arkin (1999) Ltd. 相关的药物交易
100 项与 M. Arkin (1999) Ltd. 相关的转化医学
